Totient
Latest round
- Seed
Last raised
- Sep 2020
Total raised
- $10M
Investors
- 5
About Totient
Founded in 2017 and headquartered in Cambridge, US, Totient focuses on the creation of biologic therapeutics. The company was acquired by AbSci, LLC in June 2021, although financial terms of the acquisition have not been disclosed.Totient specializes in developing biologic therapeutics, particularly through its proprietary TL1A antibody aimed at treating Inflammatory Bowel Disease (IBD). Utilizing an Integrated Drug Creation Platform, Totient employs advanced artificial intelligence and iterative lab processes to streamline drug development, reducing the time frame from conception to clinical trials to approximately 24 months.Totient generates revenue through partnerships and collaborations with pharmaceutical companies, engaging in B2B transactions. Their business model includes subscription-based agreements for access to their Integrated Drug Creation Platform, alongside milestone-driven payments associated with the successful development of drug candidates. Future products are anticipated to launch within the next few years as they continue to innovate in antibody therapeutics. The company is also looking to broaden its market reach into new geographic regions, particularly targeting Asia and Europe, to meet the growing demand for biologic treatments.
Who invested in Totient
5 investors across 1 round
See all investors in Totient
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 10, 2020
Amount
$10M
Investors
Questions about Totient
Who invested in Totient?
Totient has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Totient raised?
Totient has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Totient last raise money?
Totient's most recent round on record is a Seed, in Sep 2020.
What does Totient do?
Founded in 2017 and headquartered in Cambridge, US, Totient focuses on the creation of biologic therapeutics.
Where is Totient headquartered?
Totient is headquartered in Cambridge, US.
Which VCs invest in companies like Totient?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Totient's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Totient? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.